Illés Á - Search Results

1

Efficacy and Tolerability of a 2-Year Rituximab Maintenance Therapy in Patients with Advanced Follicular Lymphoma after Induction of Response with Rituximab-Containing First Line-Regimens (HUSOM Study).

Schneider T, Rosta A, Losonczy H, Radványi G, Ujj G, Egyed M, Illés Á, Jakucs J, Szerafin L, Gasztonyi Z, Masszi T, Iványi J, Demeter J, Dombi P, Tóth A, Borbényi Z. Schneider T, et al. Among authors: illes a. Pathol Oncol Res. 2018 Apr;24(2):199-205. doi: 10.1007/s12253-017-0234-2. Epub 2017 Apr 21. Pathol Oncol Res. 2018. PMID: 28432650 Free article. Clinical Trial.

2

[Follicular lymphoma].

Illés A, Krenács L, Borbényi Z. Illés A, et al. Orv Hetil. 2003 Nov 16;144(46):2253-61. Orv Hetil. 2003. PMID: 14702920 Review. Hungarian.

3

Retrospective analysis of the prognostic role of tissue eosinophil and mast cells in Hodgkin's lymphoma.

Keresztes K, Szollosi Z, Simon Z, Tarkanyi I, Nemes Z, Illes A. Keresztes K, et al. Among authors: illes a. Pathol Oncol Res. 2007;13(3):237-42. doi: 10.1007/BF02893504. Epub 2007 Oct 7. Pathol Oncol Res. 2007. PMID: 17922053 Free article.

4

[Hodgkin's lymphoma in adolescents: where to treat it--in an adult or pediatric institution?].

Müller J, Molnár Z, Illés A, Csóka M, Jakab Z, Deák B, Schneider T, Várady E, Rosta A, Simon Z, Keresztes K, Gergely L, Kovács G. Müller J, et al. Among authors: illes a. Orv Hetil. 2008 Nov 23;149(47):2221-7. doi: 10.1556/OH.2008.28447. Orv Hetil. 2008. PMID: 19004744 Hungarian.

5

Successful immunomodulatory therapy in castleman disease with paraneoplastic pemphigus vulgaris.

Miltenyi Z, Toth J, Gonda A, Tar I, Remenyik E, Illes A. Miltenyi Z, et al. Among authors: illes a. Pathol Oncol Res. 2009 Sep;15(3):375-81. doi: 10.1007/s12253-008-9133-x. Pathol Oncol Res. 2009. PMID: 19067241 Free article.

6

[Prognostic value of FDG-PET in Hodgkin lymphoma for posttreatment evaluation. Long-term follow-up results].

Molnár Z, Simon Z, Borbényi Z, Deák B, Galuska L, Keresztes K, Miltényi Z, Marton I, Rosta A, Schneider T, Trón L, Várady E, Illés A. Molnár Z, et al. Among authors: illes a. Orv Hetil. 2009 Nov 22;150(47):2133-8. doi: 10.1556/OH.2009.28746. Orv Hetil. 2009. PMID: 19910278 Hungarian.

7

Pretreatment T lymphocyte numbers are contributing to the prognostic significance of absolute lymphocyte numbers in B-cell non-Hodgkins lymphomas.

Gergely L, Váncsa A, Miltényi Z, Simon Z, Baráth S, Illés Á. Gergely L, et al. Among authors: illes a. Pathol Oncol Res. 2011 Jun;17(2):249-55. doi: 10.1007/s12253-010-9306-2. Epub 2010 Sep 15. Pathol Oncol Res. 2011. PMID: 20842470 Free article.

8

Adolescent hodgkin lymphoma: are treatment results more favorable with pediatric than with adult regimens?

Müller J, Illés A, Molnár Z, Rosta A, Váróczy L, Kovács G. Müller J, et al. Among authors: illes a. J Pediatr Hematol Oncol. 2011 Mar;33(2):e60-3. doi: 10.1097/MPH.0b013e3181f4686e. J Pediatr Hematol Oncol. 2011. PMID: 21285900

9

Fc-gamma-receptor IIIa polymorphism and gene expression profile do not predict the prognosis in diffuse large B-cell lymphoma treated with R-CHOP protocol.

Váróczy L, Zilahi E, Gyetvai A, Kajtár B, Gergely L, Sipka S, Illés A. Váróczy L, et al. Among authors: illes a. Pathol Oncol Res. 2012 Jan;18(1):43-8. doi: 10.1007/s12253-011-9414-7. Epub 2011 Jun 14. Pathol Oncol Res. 2012. PMID: 21667346 Free article.

10

Uncommon late relapse of angioimmunoblastic T-cell lymphoma after 16-year remission period.

Páyer E, Miltényi Z, Simon Z, Szabados L, Hegyi K, Méhes G, Illés A. Páyer E, et al. Among authors: illes a. Pathol Oncol Res. 2012 Jul;18(3):737-41. doi: 10.1007/s12253-011-9475-7. Epub 2011 Nov 30. Pathol Oncol Res. 2012. PMID: 22127590 Free article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

303 results

Search Page